Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
Date:11/9/2010

er were presented at Obesity 2010, the 28th Annual Scientific Meeting of The Obesity Society. The data presented showed that lorcaserin reduces energy intake and appetite, and causes weight loss without stimulating energy expenditure.
  • The FDA completed the Pre-Approval Inspection of Arena's drug product manufacturing facility in Switzerland and classified the inspection as No Action Indicated.
  • Results from Arena's two-year, pivotal Phase 3 BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial were published in the July 15, 2010, issue of the New England Journal of Medicine. The data presented in the article show that lorcaserin used in conjunction with behavioral modification caused significantly greater weight loss and improved maintenance of weight loss compared to placebo. The data also indicated that lorcaserin improved values for biomarkers that may be predictive of future cardiovascular events, including lipid levels, insulin resistance, levels of inflammatory markers and blood pressure.
  • Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, entered into a marketing and supply agreement with Eisai Inc. for the commercialization of lorcaserin in the United States following FDA approval of the NDA for lorcaserin. Under the terms of the agreement, Arena received a non-refundable, upfront payment of $50.0 million from Eisai.

  • Other

  • Announced that following the completion of a Phase 1 clinical trial program for APD597, Ortho-McNeil-Janssen Pharmaceuticals, Inc., decided not to advance APD597 and notified Arena that it is terminating their collaboration, effective December 28, 2010. APD597 is a GPR119 agonist intended for the treatment of type 2 diabetes, which, along with other compounds and intellectual property, will revert to Arena upon termination of the collaboration. The Phase 1 program provided evidence for incretin stimulation (GLP-1, GIP and PYY) and reducti
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
    2. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
    3. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
    4. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
    5. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
    6. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
    7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
    8. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
    9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
    10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
    11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/6/2015)... Calif. , May 6, 2015 /PRNewswire/--  Apexigen, Inc. ... innovative antibody drugs for the treatment of cancer and ... as an Innovation Partner to present at the Cavendish ... to May 14 th in ... Forum is to help family offices and foundations develop ...
    (Date:5/6/2015)... 2015 /PRNewswire/ -- Concord Medical Services Holdings Limited ("CCM" ... leading specialty hospital management solution provider and operator ... imaging centers in China , ... strategic development agreement with The University of Texas ... renowned cancer research, treatment and education center. CCM ...
    (Date:5/6/2015)...  IGI Laboratories, Inc. (NYSE-MKT: IG), a New ... presenting today at the Deutsche Bank 40th Annual Health Care ... and 7 th at The InterContinental Hotel, ... , CEO and President and Jenniffer Collins , Chief ... 6, 2015, at 3:30 p.m. ET.   The presentation will ...
    Breaking Medicine Technology:Apexigen Selected to Present at Cavendish Global Health Impact Forum 2Apexigen Selected to Present at Cavendish Global Health Impact Forum 3Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 2Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 3Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 4
    (Date:5/6/2015)... May 06, 2015 MBLM , ... and technology, announced today that its founder and president, ... Shocase, a marketing professional network aimed at connecting marketers ... Widely regarded as a specialist in the corporate identity ... branding programs over the last three decades, including the ...
    (Date:5/6/2015)... Established by the Arthritis Foundation, the month ... million Americans who suffer from arthritis. Many who battle ... their symptoms. Medicationdiscountcard.com is proud to offer a ... the costs of these necessary prescriptions. , Non-Steroidal Anti-Inflammatory ... pain and inflammation in the joints associated with arthritis. ...
    (Date:5/6/2015)... York, NY (PRWEB) May 06, 2015 ... and long-standing organization dedicated to activating and celebrating ... its Champion organization, Highmark Health, as an Outstanding ... partnership with the Jefferson Awards Foundation, are dedicated ... communities. For nearly a decade, Highmark Health has ...
    (Date:5/6/2015)... 2015 Stout Industries is owned ... Paso and Austin, Texas fire departments. Stout Industries recently developed ... three main components to these fire safety devices. The ... the power is turned on. They light the area within ... what is on the roof, preventing leg and ankle injuries. ...
    (Date:5/6/2015)... Launch Corporation, LLC. is pleased to announce that Launch ... 17 Tanguay Avenue. Owned and operated by Rick Arnold and ... in New England. , “We are extremely excited for Rick ... co-owner and CEO of Launch. “They have established great roots ... them continue to establish that positive growth in the greater ...
    Breaking Medicine News(10 mins):Health News:Shocase Selects MBLM’s Claude Salzberger as Company Advisor 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4Health News:Kickstarter for FIRE Lights, the New Fire Safety Devices 2Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2
    ... Many of the side effects from chemotherapy are well ... there is another one that has split the medical ... cognitive deficits or "chemo fog" and pharmacologist Ellen Walker ... finds the cause. , Walker, a PhD and associate ...
    ... reduces the breast cancer risk of women. However, it had ... which period in life in order to benefit from this ... of breast cancer is influenced by physical activity. , ... of the MARIE study, in which 3,464 breast cancer patients ...
    ... Indianapolis-based firm that,improves organizational success through human ... in Detroit, Michigan, have,finalized an agreement to ... basis of,the new Adayana Healthcare Group. , ... Gradepoint develops enterprise learning programs,through four unique ...
    ... Group announced today that in the year just ... with local employers reached more than 70,000 employees ... healthcare costs as America confronts such growing problems ... the same time, hospitals partnering with Aegis reported ...
    ... Larger Tip Enables Physicians to Perform Thermage Body Area ... Calif., Jan. 15 Solta Medical, Inc. (Nasdaq: ... new Body Tip 16.0 for the Thermage NXT system ... treatments. With five times the surface area coverage of ...
    ... Health survey of spouses reveals little exercise, a wish for weight ... ST. LOUIS, Jan. 15 A recent ... own health and that of their spouses, may not sync up ... (NYSE: ENR ), more than seven out of ten ...
    Cached Medicine News:Health News:Clearing the 'fog' 2Health News:Clearing the 'fog' 3Health News:Reduced breast cancer risk: Physical activity after menopause pays off 2Health News:Adayana, Inc. Acquires Gradepoint, a Detroit-Based Enterprise Learning Company 2Health News:Hospital-Employer Partnerships Growing as Employers Seek Ways to Improve Health and Manage Dollars in Tough Economic Times 2Health News:Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments 2Health News:Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments 3Health News:He Said, She Said: Boomers Rate Their Spouses' Health 2Health News:He Said, She Said: Boomers Rate Their Spouses' Health 3Health News:He Said, She Said: Boomers Rate Their Spouses' Health 4
    ... functions over a wide range of ... delivering more thorough characterization than other ... the relative change in the distribution ... way to measure heterogeneity, stoichiometry and ...
    Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 1000 mg/dL (11.3 mmol/L). Single vial, dry powder reagent....
    Alkaline phosphatase FS (DGKC new; 37C). For determination of alkaline phosphatase (ALP) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
    For the quantitative determination of alkaline phosphatase in human serum....
    Medicine Products: